Truist Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-19,069
| Closed | -$448K | – | 2503 |
|
|
2024
Q2 | $448K | Sell |
19,069
-127
| -0.7% | -$2.98K | ﹤0.01% | 2024 |
|
|
2024
Q1 | $552K | Sell |
19,196
-1,411
| -7% | -$40.6K | ﹤0.01% | 1902 |
|
|
2023
Q4 | $676K | Sell |
20,607
-313
| -1% | -$10.3K | ﹤0.01% | 1805 |
|
|
2023
Q3 | $583K | Buy |
20,920
+889
| +4% | +$24.8K | ﹤0.01% | 1835 |
|
|
2023
Q2 | $683K | Buy |
20,031
+1,266
| +7% | +$43.2K | ﹤0.01% | 1783 |
|
|
2023
Q1 | $564K | Buy |
18,765
+2,763
| +17% | +$83.1K | ﹤0.01% | 1897 |
|
|
2022
Q4 | $452K | Buy |
16,002
+559
| +4% | +$15.8K | ﹤0.01% | 2023 |
|
|
2022
Q3 | $507K | Sell |
15,443
-2,639
| -15% | -$86.6K | ﹤0.01% | 1805 |
|
|
2022
Q2 | $569K | Sell |
18,082
-36,683
| -67% | -$1.15M | ﹤0.01% | 1828 |
|
|
2022
Q1 | $2.52M | Sell |
54,765
-13,888
| -20% | -$638K | ﹤0.01% | 1196 |
|
|
2021
Q4 | $4.2M | Sell |
68,653
-7,715
| -10% | -$472K | 0.01% | 949 |
|
|
2021
Q3 | $5.71M | Sell |
76,368
-47,408
| -38% | -$3.54M | 0.01% | 825 |
|
|
2021
Q2 | $11.4M | Buy |
123,776
+9,789
| +9% | +$905K | 0.02% | 584 |
|
|
2021
Q1 | $10.1M | Buy |
113,987
+77,683
| +214% | +$6.89M | 0.02% | 588 |
|
|
2020
Q4 | $3.39M | Buy |
36,304
+29,250
| +415% | +$2.73M | 0.01% | 966 |
|
|
2020
Q3 | $449K | Buy |
7,054
+2,195
| +45% | +$140K | ﹤0.01% | 1758 |
|
|
2020
Q2 | $253K | Buy |
+4,859
| New | +$253K | ﹤0.01% | 2048 |
|